Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR

Molecular and Cellular Biology

Volumn 23, Issue 14, 2003, Pages 4901-4916

  Akool, El Sayed ^a,c   Kleinert, Hartmut ^b   Hamada, Farid M A ^c   Abdelwahab, Mohamed H ^c   Förstermann, Ulrich ^b   Pfeilschifter, Josef ^a   Eberhardt, Wolfgang ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Al Azhar University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 8 BROMO CYCLIC GMP; CYTOKINE; GELATINASE B; GUANYLATE CYCLASE INHIBITOR; HUR PROTEIN; INTERLEUKIN 1BETA; LUCIFERASE; MESSENGER RNA; NITRIC OXIDE; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STABILITY; EXTRACELLULAR MATRIX; GEL MOBILITY SHIFT ASSAY; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPORTER GENE; RNA BINDING;

3' UNTRANSLATED REGIONS; AMINOQUINOLINES; ANIMALS; ANTIGENS, SURFACE; BASE SEQUENCE; CELLS, CULTURED; CYCLIC GMP; CYTOPLASM; DACTINOMYCIN; ENZYME INHIBITORS; GENE EXPRESSION; GUANYLATE CYCLASE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; INTERLEUKIN-1; KIDNEY; MATRIX METALLOPROTEINASE 9; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSO COMPOUNDS; RATS; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; RIBONUCLEOPROTEINS; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS;

ANIMALIA;

EID: 0038788884     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.14.4901-4916.2003     Document Type: Article

References (67)

1. Abdelaziz, N., F. Colombo, I. Mercier, and A. Calderone. 2001. Nitric oxide attenuates the expression of transforming growth factor-β (3) mRNA in rat cardiac fibroblasts via destabilization. Hypertension 38:261-266.
2. Aharon, T., and R. J. Schneider. 1993. Selective destabilization of short-lived mRNAs with the granulocyte-macrophage colony-stimulating factor AU-rich 3′ noncoding region is mediated by a cotranslational mechanism. Mol. Cell. Biol. 13:1971-1980.
3. Antic, D., N. Lu, and J. D. Keene. 1999. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev. 13:449-461.
4. Atasoy, U., J. Watson, D. Patel, and J. D. Keene. 1998. ELAV protein HuA (HuR) can redistribute between nucleus and cytoplasm and is upregulated during serum stimulation and T cell activation. J. Cell Sci. 111:3145-3156.
5. Biragyn, A., and S. A. Nedospasov. 1995. Lipopolysaccharide-induced expression of TNFα gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. J. Immunol. 155:674-683.
6. Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. 1991. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′ untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11:3288-3295.
7. Brennan, C. M., and J. A. Steitz. 2001. HuR and mRNA stability. Cell. Mol. Life Sci. 58:266-277.
8. Brinckerhoff, C. E., and L. M. Matrisian. 2002. Matrix metalloproteinases: a tail of a frog that became a prince. Nat. Rev. Mol. Cell Biol. 3:207-214.
9. Cawston, T. 1998. Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol. Med. Today 4:130-137.
10. Chen, C.-Y., and A.-B. Shyu. 1994. Selective degradation of early-responsegene mRNAs: functional analysis of sequence features of the AU-rich elements. Mol. Cell. Biol. 14:8471-8482.
11. Chen, C.-Y., N. Xu, and A.-B. Shyu. 1995. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol. Cell. Biol. 15:5777-5788.
12. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
13. Dani, C., N. Mechti, M. Piechaczyk, B. Lebleu, P. Jeanteur, and J. M. Blanchard. 1985. Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc. Natl. Acad. Sci. USA 82:4896-4899.
14. Davies, M., J. Martin, G. J. Thomas, and D. H. Lovett. 1992. Proteinases and glomerular matrix turnover. Kidney Int. 41:671-678.
15. Dean, J. L., R. Wait, K. R. Mahtani, G. Sully, A. R. Clark, and J. Saklatvala. 2001. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol. 21:721-730.
16. Di Marco, S., Z. Hel, C. Lachance, H. Furneaux, and D. Radzioch. 2001. Polymorphism in the 3′-untranslated region of TNFα mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFα mRNA. Nucleic Acids Res. 29:863-871.
17. Dixon, D. A., N. D. Tolley, P. H. King, L. B. Nabors, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2001. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Investig. 108:1657-1665.
18. Dreyfuss, G., M. Hentze, A. I. Lamond. 1996. From transcript to protein. Cell 85:963-972.
19. Eberhardt, W., T. Beeg, K. F. Beck, S. Walpen, S. Gauer, H. Bohles, and J. Pfeilschifter. 2000. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int. 57:59-69.
20. Eberhardt, W., A. Huwiler, K. F. Beck, S. Walpen, and J. Pfeilschifter. 2000. Amplification of IL-1 β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-κ B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165:5788-5797.
21. Eberhardt, W., K. F. Beck, and J. Pfeilschifter. 2002. Cytokine-induced expression of tPA is differentially modulated by NO and ROS in rat mesangial cells. Kidney Int. 61:20-30.
22. Eberhardt, W., M. Schulze, C. Engels, E. Klasmeier, and J. Pfeilschifter. 2002. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-κB and Ets transcription factors. Mol. Endocrinol. 16:1752-1766.
23. Eberhardt, W., el-S. Akool, J. Rebhan, S. Frank, K. F. Beck, R. Franzen, F. M. Hamada, and J. Pfeilschifter. 2002. Inhibition of cytokine-induced matrix metalloproteinase 9 expression by peroxisome proliferator-activated receptor α agonists is indirect and due to a NO-mediated reduction of mRNA stability. J. Biol. Chem. 277:33518-33528.
24. Ehrenman, K., L. Long, B. J. Wagner, and G. Brewer. 1994. Characterization of cDNAs encoding the murine A+U-rich RNA-binding protein AUF1. Gene 149:315-319.
25. Fan, X. C., and J. A. Steitz. 1998. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448-3460.
26. Ford, L. P., J. Watson, J. D. Keene, and J. Wilusz. 1999. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev. 13:188-201.
27. Grzybowska, E. A., A. Wilczynska, and J. A. Siedlecki. 2001. Regulatory functions of 3′ UTRs. Biochem. Biophys. Res. Commun. 288:291-295.
28. Henics, T., A. Sanfridson, B. J. Hamilton, E. Nagy, and W. F. Rigby. 1994. Enhanced stability of interleukin-2 mRNA in MLA 144 cells. Possible role of cytoplasmic AU-rich sequence-binding proteins. J. Biol. Chem. 269:5377-5383.
29. Keene, J. D. 1999. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA 96:5-7.
30. Kunz, D., H. Mühl, G. Walker, and J. Pfeilschifter. 1994. Two distinct signalling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc. Natl. Acad. Sci. USA 91:5387-5391.
31. Lander, H. M., P. Sehajpal, D. M. Levine, and A. Novogrodsky. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509-1516.
32. Lenz, O., S. J. Elliot, and W. G. Stetler-Stevenson. 2000. Matrix metalloproteinases in renal development and disease. J. Am. Soc. Nephrol. 11:574-581.
33. Levy, A. P., N. S. Levy, and M. A. Goldberg. 1996. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271:2746-2753.
34. Ma, W. J., S. Cheng, C. Campbell, A. Wright, and H. Furneaux. 1996. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J. Biol. Chem. 271:8144-8151.
35. Malter, J. S. 1989. Identification of an AUUUA-specific messenger RNA binding protein. Science 246:664-666.
36. Murrell, G. A., D. Jang, and R. J. Williams. 1995. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 206:15-21.
37. Nabors, L. B., G. Y. Gillespie, L. Harkins, and P. H. King. 2001. HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res. 61:2154-2161.
38. Nagase, H., and J. F. Woessner, Jr. 1999. Matrix metalloproteinases. J. Biol. Chem. 274:21491-21494.
39. Nair, A. P., S. Hahn, R. Banholzer, H. H. Hirsch, and C. Moroni. 1994. Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA. Nature 369:239-242.
40. Peng, S. S., C. Y. Chen, N. Xu, and A. B. Shyu. 1998. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17:3461-3470.
41. Perez-Sala, D., E. Cernuda-Morollon, M. Diaz-Cazorla, F. Rodriguez-Pascual, and S. Lamas. 2001. Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am. J. Physiol. 280:F466-F473.
42. Pfeilschifter, J., and H. Schwarzenbach. 1990. Interleukin 1 and tumor necrosis factor stimulate cGMP formation in rat renal mesangial cells. FEBS Lett. 273:185-187.
43. Pfeilschifter, J., and K. Vosbeck. 1991. Transforming growth factor β 2 inhibits interleukin 1β- and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem. Biophys. Res. Commun. 175:372-379.
44. Pfeilschifter, J., W. Eberhardt, and A. Huwiler. 2001. Nitric oxide and mechanisms of redox signalling: matrix and matrix-metabolizing enzymes as prime nitric oxide targets. Eur. J. Pharmacol. 429:279-286.
45. Pfeilschifter, J., K. F. Beck, W. Eberhardt, and A. Huwiler. 2002. Changing gears in the course of glomerulonephritis by shifting superoxide to nitric oxide-dominated chemistry. Kidney Int. 61:809-815.
46. Pineda-Molina, E., and S. Lamas. 2001. Nitric oxide as a regulator of gene expression: studies with the transcription factor proteins cJun and p50. Biofactors 15:113-135.
47. Rabbitts, P. H., A. Forster, M. A. Stinson, and T. H. Rabbitts. 1985. Truncation of exon 1 from the c-myc gene results in prolonged c-myc mRNA stability. EMBO J. 4:3727-3733.
48. Rodriguez-Pascual, F., M. Hausding, I. Ihrig-Biedert, H. Furneaux, A. P. Levy, U. Forstermann, and H. Kleinert. 2000. Complex contribution of the 3′-untranslated region to the expressional regulation of the human inducible nitric-oxide synthase gene. Involvement of the RNA-binding protein HuR. J. Biol. Chem., 275:26040-26049.
49. Ross, J. 1995. mRNA stability in mammalian cells. Microbiol. Rev. 59:423-450.
50. Schmidt, H. H., and U. Walter. 1994. NO at work. Cell 78:919-925.
51. Stoeckle, M. Y. 1991. Post-transcriptional regulation of gro alpha, beta, gamma, and IL-8 mRNAs by IL-1β. Nucleic Acids Res. 19:917-920.
52. Trachtman, H., S. Futterweit, P. Garg, K. Reddy, and P. C. Singhal. 1996. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 218:704-708.
53. Villarete, L. H., and D. G. Remick. 1996. Transcriptional and post-transcriptional regulation of interleukin-8. Am. J. Pathol. 149:1685-1693.
54. von Knethen, A., and B. Brüne. 2000. Superinduction of cyclooxygenase-2 by NO(*) and agonist challenge involves transcriptional regulation mediated by AP-1 activation. Biochemistry 39:1532-1540.
55. Walpen, S., K. F. Beck, W. Eberhardt, M. Apel, P. K. Chatterjee, G. M. Wray, C. Thiemermann, and J. Pfeilschifter. 2000. Downregulation of SPARC expression is mediated by nitric oxide in rat mesangial cells and during endotoxemia in the rat. J. Am. Soc. Nephrol. 11:468-476.
56. Wang, W., M. C. Caldwell, S. Lin, H. Furneaux, and M. Gorospe. 2000. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J. 19:2340-2350.
57. Wang, W., J. Fan, X. Yang, S. Furer-Galban, I. Lopez de Silanes, C. von Kobbe, J. Guo, S. N. Georas, F. Foufelle, D. G. Hardie, D. Carling, and M. Gorospe. 2002. AMP-activated kinase regulates cytoplasmic HuR. Mol. Cell. Biol. 22:3425-3436.
58. Wickens, M., P. Anderson, and R. J. Jackson. 1997. Life and death in the cytoplasm: messages from the 3′ end. Curr. Opin. Genet. Dev. 7:220-232.
59. Wilson, G. M., Y. Sun, J. Sellers, H. Lu, N. Penkar, G. Dillard, and G. Brewer. 1999. Regulation of AUF1 expression via conserved alternatively spliced elements in the 3′ untranslated region. Mol. Cell. Biol. 19:4056-4064.
60. Winzen, R., M. Kracht, B. Ritter, A. Wilhelm, C. Y. Chen, A. B. Shyu, M. Muller, M. Gaestel, K. Resch, and H. Holtmann. 1999. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18:4969-4980.
61. Woessner, J. F., Jr. 1998. The matrix metalloproteinase family, p. 1-13. In W. C. Parks and R. P. Mecham (ed.), Matrix metalloproteinases. Academic Press, San Diego, Calif.
62. Woessner, J. F., Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145-2154.
63. Xu, K., A. M. Robida, and T. J. Murphy. 2000. Immediate-early MEK-1-dependent stabilization of rat smooth muscle cell cyclooxygenase-2 mRNA by G α(q)-coupled receptor signaling. J. Biol. Chem. 275:23012-23019.
64. Xu, N., C.-Y. Chen, and A.-B. Shyu. 1997. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol. Cell. Biol. 17:4611-4621.
65. Yokoo, T., and M. Kitamura. 1996. Dual regulation of IL-1β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1. Am. J. Physiol. 270:123-130.
66. Zaragoza, C., M. Balbin, C. Lopez-Otin, and S. Lamas. 2002. Nitric oxide regulates matrix metalloprotease-13 expression and activity in endothelium. Kidney Int. 61:804-808.
67. Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. DeMaria, D. Crater, K. DeHaven, L. Long, and G. Brewer. 1993. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13:7652-7665.